focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,405.00
Bid: 2,210.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 195.00 (8.824%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,405.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Apr 2024 07:00

RNS Number : 7048K
Oxford Instruments PLC
16 April 2024
 

 

Oxford Instruments plc

Trading Update - 16 April 2024

 

 

Full year trading in line with expectations

Positive momentum in revenue growth

 

Oxford Instruments plc, a leading global provider of scientific technology and expertise to academic and commercial partners, is today issuing a trading update for the year ended 31 March 2024.

 

Revenue growth for the year has been strong and is expected to be up around 9% at constant currency (6% at actual rates) on the prior year. Our differentiated positions are driving positive momentum, with growth across all our geographies in our key sustainability-driven and structurally growing end markets, including advanced materials, life science and semiconductors. While orders were lower against a strong comparator year and due to a slowdown in life science OEM orders, our underlying book-to-bill remains positive.

 

Operating margin is expected to be approximately 100bps behind last year, reflecting losses incurred in our quantum business as a result of ceasing commercial activities in China, and continued operational investment.

 

We expect adjusted operating profit for the full year ended 31 March 2024 to be in line with expectations.1

 

The Group enters the new financial year with a strong order book providing good visibility to planned revenues and a good pipeline of growth opportunities in structurally growing end markets.

 

Oxford Instruments' results for the year ending 31 March 2024 will be released on 11 June 2024, together with an update on the Group's strategy.

 

On 10 July 2024, we will host an investor and analyst site visit at our new etch and deposition systems facility in Bristol, which is now operational. The focus will be on the products and services we provide within the compound semiconductor industry.

 

 

 

Notes:

 

1 Adjusted operating profit is before amortisation and impairment of acquired intangible assets, acquisition items, and the mark-to-market revaluation of financial derivatives.

 

 

 

Enquiries:

 

Oxford Instruments plc

Richard Tyson, CEO

Gavin Hill, CFO

Stephen Lamacraft, Head of Investor Relations

Tel: 01865 393200

 

 

MHP

Katie Hunt/Tim Rowntree/Eleni Menikou/Veronica Farah

oxfordinstruments@mhpc.com

Tel: 020 3128 8100

 

 

 

 

- Ends -

 

Issued for and on behalf of Oxford Instruments plc

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies andsupports high-technology products and systems which allow the world's leading companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level. The Group's products and services help its customers to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries across its key market segments: Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, Energy & Environment and Quantum Technology.

Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to enable a greener, healthier, more connected advanced society. Founded in 1959 as the first technology business to be spun out fromOxfordUniversity, Oxford Instruments is now a global company listed on the FTSE250 index of the London Stock Exchange (OXIG). Its customer-centric, market-focused strategy creates competitive advantage through understanding the technical and commercial challenges in markets with long-term structural growth drivers.

 

For more information, visit www.oxinst.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKPBBFBKDKQD
Date   Source Headline
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn
30th Jul 202012:03 pmRNSPrice Monitoring Extension
24th Jul 202012:07 pmRNSSecond Price Monitoring Extn
24th Jul 202012:02 pmRNSPrice Monitoring Extension
23rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
23rd Jul 202012:02 pmRNSPrice Monitoring Extension
22nd Jul 202012:08 pmRNSSecond Price Monitoring Extn
22nd Jul 202012:02 pmRNSPrice Monitoring Extension
21st Jul 20204:10 pmPRNHolding(s) in Company
16th Jul 202012:07 pmRNSSecond Price Monitoring Extn
16th Jul 202012:02 pmRNSPrice Monitoring Extension
14th Jul 20201:43 pmPRNNotice of AGM
14th Jul 202012:02 pmRNSPrice Monitoring Extension
13th Jul 20201:35 pmPRNDirector/PDMR Shareholding
9th Jul 202010:13 amPRNTotal Voting Rights
6th Jul 202012:02 pmRNSPrice Monitoring Extension
2nd Jul 20203:50 pmPRNBlocklisting - Interim Review
2nd Jul 20209:37 amPRNHolding(s) in Company
25th Jun 20209:55 amPRNHolding(s) in Company
25th Jun 20209:34 amPRNHolding(s) in Company
11th Jun 202012:07 pmPRNDirector/PDMR Shareholding
10th Jun 202012:02 pmRNSPrice Monitoring Extension
9th Jun 20207:00 amRNSAppointment of Independent Non-Executive Director
9th Jun 20207:00 amRNSPreliminary Results
2nd Jun 202010:41 amPRNTotal Voting Rights
18th May 202012:07 pmRNSSecond Price Monitoring Extn
18th May 202012:02 pmRNSPrice Monitoring Extension
12th May 20201:32 pmPRNDirector/PDMR Shareholding
7th May 20205:07 pmPRNTotal Voting Rights
5th May 202012:02 pmRNSPrice Monitoring Extension
4th May 20208:27 amPRNDisclosure of Rights Attached to Equity Shares
1st May 202012:07 pmRNSSecond Price Monitoring Extn
1st May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:07 pmRNSSecond Price Monitoring Extn
30th Apr 202012:02 pmRNSPrice Monitoring Extension
27th Apr 202012:03 pmRNSPrice Monitoring Extension
24th Apr 202012:02 pmRNSPrice Monitoring Extension
21st Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 202010:51 amPRNDirector/PDMR Shareholding
3rd Apr 202012:39 pmPRNDirector Declaration
1st Apr 202012:03 pmRNSPrice Monitoring Extension
1st Apr 202010:06 amPRNHolding(s) in Company
30th Mar 20207:00 amRNSSuspension of Interim Dividend
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSTrading Update
12th Mar 202011:11 amPRNDirector/PDMR Shareholding
4th Mar 202010:02 amPRNAppointment of External Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.